Illustrative image – not actual.Bharat Biotech International is planning to expand the production capacity of vaccines as well as increasing R&D activities. The expansion programme would entail an investment of Rs.100 crore.
International Finance Corporation is expected to fund around Rs.30 crore for the project.
Bharat Biotech is primarily involved in three activities which include development and production of vaccines, contract development and manufacturing for overseas companies, and development of its own line of molecules. The company has the second largest biotech plant in the world with a capacity of 100 million doses of Hepatitis B vaccine.
